IRIS
BASSETTI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.773
AS - Asia 7.972
EU - Europa 5.665
SA - Sud America 1.268
AF - Africa 163
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 7
Totale 41.876
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.562
SG - Singapore 3.638
CN - Cina 1.671
UA - Ucraina 1.379
IT - Italia 1.060
BR - Brasile 1.010
HK - Hong Kong 870
DE - Germania 763
SE - Svezia 653
VN - Vietnam 628
TR - Turchia 488
RU - Federazione Russa 370
FR - Francia 322
IE - Irlanda 277
FI - Finlandia 252
GB - Regno Unito 215
IN - India 166
BD - Bangladesh 109
AR - Argentina 105
NL - Olanda 88
CA - Canada 78
MX - Messico 74
IQ - Iraq 58
JP - Giappone 53
AT - Austria 50
PL - Polonia 44
ZA - Sudafrica 44
EC - Ecuador 41
BE - Belgio 38
PK - Pakistan 36
CO - Colombia 33
ES - Italia 31
EU - Europa 25
SA - Arabia Saudita 25
ID - Indonesia 24
KR - Corea 24
UZ - Uzbekistan 24
CZ - Repubblica Ceca 21
CL - Cile 20
PE - Perù 20
JO - Giordania 19
MA - Marocco 19
KE - Kenya 18
PH - Filippine 17
RS - Serbia 14
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
JM - Giamaica 12
VE - Venezuela 12
IR - Iran 11
TN - Tunisia 11
BO - Bolivia 10
DZ - Algeria 10
LT - Lituania 10
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
NP - Nepal 9
RO - Romania 9
CH - Svizzera 8
ET - Etiopia 8
HU - Ungheria 8
TH - Thailandia 8
AO - Angola 7
CR - Costa Rica 7
DK - Danimarca 7
LV - Lettonia 7
EG - Egitto 6
IL - Israele 6
LB - Libano 6
MY - Malesia 6
OM - Oman 6
BG - Bulgaria 5
GH - Ghana 5
GR - Grecia 5
NI - Nicaragua 5
PT - Portogallo 5
AM - Armenia 4
GT - Guatemala 4
HN - Honduras 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AL - Albania 3
AU - Australia 3
BW - Botswana 3
CY - Cipro 3
GE - Georgia 3
LK - Sri Lanka 3
MM - Myanmar 3
MN - Mongolia 3
MZ - Mozambico 3
NG - Nigeria 3
PA - Panama 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
Totale 41.815
Salva come PNG Salva come JPEG
Città #
Fairfield 3.666
Woodbridge 3.349
Houston 2.258
Ashburn 2.095
Ann Arbor 1.932
Singapore 1.535
Seattle 1.470
Chandler 1.364
Wilmington 1.313
Cambridge 1.302
Hong Kong 852
Dearborn 815
Beijing 743
Jacksonville 689
Izmir 453
Boardman 439
San Jose 406
Princeton 300
Dublin 273
Lauterbourg 270
Los Angeles 204
Udine 190
Council Bluffs 181
San Diego 175
Des Moines 166
Dong Ket 158
Ho Chi Minh City 151
Dallas 142
Redondo Beach 118
Buffalo 113
Hanoi 107
Falls Church 94
Milan 92
Santa Clara 91
São Paulo 88
New York 83
Andover 74
Hefei 68
Frankfurt am Main 67
Norwalk 64
Munich 63
Nanjing 55
Ogden 51
Rome 51
Helsinki 50
The Dalles 49
Tokyo 47
Phoenix 46
Guangzhou 40
Kunming 40
Warsaw 38
Brussels 37
Orem 36
Nuremberg 35
Chicago 33
Rio de Janeiro 33
Shanghai 33
Redmond 32
Chennai 30
Grafing 30
Trieste 30
Jinan 28
Atlanta 27
London 27
Fuzhou 26
Montreal 26
Baghdad 25
Naples 25
Brooklyn 24
Johannesburg 24
Vienna 24
Belo Horizonte 23
Denver 22
Haiphong 22
Mexico City 21
Mumbai 21
Turin 21
Amsterdam 20
Bologna 20
Fremont 20
Toronto 20
Curitiba 19
Stockholm 19
Tashkent 19
Da Nang 18
Palermo 18
Quito 18
Redwood City 18
Amman 17
Boston 17
Nanchang 17
Venezia 17
Zhengzhou 17
Brasília 16
Brno 16
Buenos Aires 16
Dhaka 16
San Francisco 16
Wuhan 16
Istanbul 15
Totale 29.600
Salva come PNG Salva come JPEG
Nome #
Terapia e profilassi delle infezioni 461
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 278
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis 261
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 250
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 246
The management of multidrug-resistant enterobacteriaceae 245
Antibiotic-resistant Pseudomonas aeruginosa: Focus on care in patients receiving assisted ventilation 243
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 227
Delafloxacin for the treatment of respiratory and skin infections 220
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 216
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 212
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: Results from an observational prospective study in elective surgery 205
Management of reduced vaccine coverage due to 6 years of failure to vaccinate: The Codroipo case, Italy 205
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 203
Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance 199
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 193
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 191
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 188
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 186
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 186
Task force on management and prevention of Acinetobacter baumannii infections in the ICU 184
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 184
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15) 183
Advances in antibiotic therapy in the critically ill 183
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 183
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 181
New therapeutic options for respiratory tract infections 179
Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report 178
Safety of long-term use of linezolid: Results of an open-label study 177
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients 177
Hot topics in necrotising skin and soft tissue infections 177
Ceftolozane/tazobactam: place in therapy 177
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamaseproducing Enterobacteriaceae in haematological patients with neutropaenia: A study protocol for a retrospective observational study (BICAR) 177
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 177
Diagnosis and management of invasive candidiasis in the ICU: An updated approach to an old enemy 176
An Italian consensus for invasive candidiasis management (ITALIC) 176
Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy 175
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 175
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 173
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy 173
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 173
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives 173
Current and future therapies for invasive aspergillosis 172
Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens 172
Resistance mechanisms and epidemiology of multiresistant pathogens in europe and efficacy of tigecycline in observational studies 172
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 172
Different miRNA expression in transplanted livers of HCV mono-infected and HCV/HIV co-infected recipients 172
Impact of new treatment options for hepatitis c virus infection in liver transplantation 172
DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients? 171
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics 171
Tick-borne encephalitis in North-East Italy: A 14-year retrospective study, January 2000 to December 2013 171
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 170
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 170
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies 170
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics 170
Serological and T Cell Responses after Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis 169
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient 168
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update 168
Focus on optimization of early antimicrobial therapy in ICU-acquired infections 167
Efficacy of tigecycline for the treatment of complicated intraabdominal infections in real-life clinical practice from five european observational studies 167
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 167
A survey on infection management practices in Italian ICUs 167
The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections 167
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study 167
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU 166
New therapeutic options for skin and soft tissue infections 166
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 165
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB? 165
Linezolid underexposure in a patient co-treated with venlafaxine 164
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study-authors' response 164
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe 164
Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: A call for international guidelines 163
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: A critical agenda 163
Development of novel antibacterial drugs to combat multiple resistant organisms 162
Eravacycline for the treatment of intra-abdominal infections 162
Infezioni delle vie urinarie: appropriatezza in antibioticoterapia 161
The role of dalbavancin in skin and soft tissue infections 161
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? 161
Epidemiology, species distribution, antifungal susceptibility, and outcome of Candidemia across five sites in Italy and Spain 161
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 161
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 161
Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa 160
First report of endocarditis by Gluconobacter spp. in a patient with a history of intravenous-drug abuse 160
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data 159
Intensive care unit patients with lower respiratory tract nosocomial infections: The ENIRRIs project 158
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 158
Epidemiology and predictors of recurrence of Clostridium difficile infection in a North Italian tertiary care hospital 157
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 156
Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria 156
Predicting the occurrence of embolic events: An analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI) 156
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 156
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 155
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation 155
Intratracheal administration of antimicrobial agents in mechanically ventilated adults: An international survey on delivery practices and safety 155
"Salvage treatment" for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal 155
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 155
Prosthetic joints: Shining lights on challenging blind spots 155
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 155
Designing a pathogen-focused study to address the high unmet medical need represented by carbapenem-resistant gram-negative pathogens – the international, multicenter, randomized, open-label, phase 3 credible-cr study 155
Fungal endogenous endophthalmitis secondary to magnusiomyces capitatus 155
Totale 17.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.721
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.808 175 220 223 157 55 197 219 104 49 443 502 464
2022/20233.147 340 150 42 411 353 902 1 230 524 35 77 82
2023/2024829 160 103 40 22 188 73 33 42 84 34 14 36
2024/20254.553 137 357 226 220 138 259 221 354 565 405 457 1.214
2025/20268.542 646 908 680 665 1.424 888 1.165 304 542 647 433 240
2026/2027240 240 0 0 0 0 0 0 0 0 0 0 0
Totale 43.106